The 7 analysts offering 12-month price forecasts for UNITY Biotechnology Inc have a median target of 6.00, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +380.00% increase from the last price of 1.25.
The current consensus among 7 polled investment analysts is to Buy stock in UNITY Biotechnology Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.33
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.